about
CD47 regulates bone mass and tumor metastasis to boneImmune regulation of bone metastasisBiology of bone metastases.PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cellsThe reaction of bone to tumor growth from human breast cancer cells in a rat spine single metastasis model.Regulation of postnatal trabecular bone formation by the osteoblast endothelin A receptor.Molecular biology and therapeutics in musculoskeletal oncology.The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblastsMetastatic bone disease: role of transcription factors and future targets.Mammary gland serotonin regulates parathyroid hormone-related protein and other bone-related signalsIntegrins and bone metastasis: integrating tumor cell and stromal cell interactions.Breast cancer at bone metastatic sites: recent discoveries and treatment targets.Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cellsBone-immune cell crosstalk: bone diseases.Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical PracticeDisseminated prostate cancer cells can instruct hematopoietic stem and progenitor cells to regulate bone phenotype.Bone-modifying agents in the treatment of bone metastases in patients with advanced genitourinary malignancies: a focus on zoledronic acid.Radiographic characteristics of bone metastases from hepatocellular carcinomaEcological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments.Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments.Optimal management of bone metastases in breast cancer patients.Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells.Neurosurgery concepts: Key perspectives on imaging characteristics of spinal metastases, surgery for low back pain, anesthesia for disc surgery, and laminectomy versus laminectomy and fusion for lumbar spondylolisthesis.Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells.Bone metastasis in prostate cancer: emerging therapeutic strategies.Clinical usefulness of bone markers in prostate cancer with bone metastasis.Novel bone-targeting agents in prostate cancer.Differences of osteoblastic bone metastases and osteolytic bone metastases in clinical features and molecular characteristics.Metabolism and pharmacokinetics of radium-223 in prostate cancer.Wnt/β-catenin signaling in bone marrow niche.Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells.The surgical management and treatment of metastatic lesions in the proximal femur: A mini review.TGFβ1-Endo180-dependent collagen deposition is dysregulated at the tumour-stromal interface in bone metastasis.Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1.Hypercalcemia of malignancy treated with cinacalcet.A mathematical model for describing the metastasis of cancer in bone tissue.Patient preferences for treatments to delay bone metastases.Paclitaxel-loaded polyphosphate nanoparticles: a potential strategy for bone cancer treatment
P2860
Q24651925-0DBAAFFF-D5AC-4CD0-882C-C46DEE2C7B9AQ27005871-6D28AD15-2EFF-4EB9-9851-FF943C4E30F8Q27693653-9AA60888-AA9B-47A7-B60C-30D8BDCB78E3Q28395725-192F410C-1856-4A91-8BEF-2E52B2B661B2Q30415248-42000CE5-C103-4B20-8196-26B1D35689A2Q30424724-381CFBD8-77A9-4020-B56A-481DFD9D5118Q30426953-3E9FFEA1-A8A4-45B8-A06C-DB693AE25465Q33610879-8AC8DD8C-B531-471A-B554-1121D5DD0354Q34217531-6D45FF81-C718-4B70-B94B-F7EF9D6D34ABQ34253136-A8742D61-1E17-4427-B91B-BC683BAD33F8Q34441622-5A393D78-B22C-460C-9880-D79C9EBF1864Q34939979-F91E471F-FC63-465C-B8FA-7E7C762DA976Q34967135-6FCEBB39-68A8-4EE1-90CE-88B5E9D0B81FQ35592362-A6569AB6-C84A-4517-9AF0-12049F67EB14Q35667196-1B47C9C3-E24B-4511-BA2A-F08FECE35FA7Q35840465-ED74E616-91D6-481F-90B4-C4726E3DEF0DQ35865726-32C98E3F-04CB-4FA6-BD6B-59FE1D00886DQ36942650-470FFA93-92E0-4D1F-8B51-0D5B8F5F952FQ36970516-816A1674-9C70-4E36-8BD6-8B8E9022A103Q37187646-3A812106-DD28-495F-82CF-66478585B4AAQ37355487-6392892B-496F-46B8-B99A-7B773C28ED05Q37435382-F9846623-2AC4-4A56-8793-E30E42DB83BCQ37620985-E8467529-B113-4C3C-BEF3-7C257261ACD0Q37694746-26178FD0-B48F-4132-A8A6-E38DC8AC2982Q37873719-FFC8BAF6-90FE-4931-9A48-EC317E0009F4Q38026966-3F201471-DE4F-412F-8FB5-EF1FD130ECECQ38198934-75856A0E-149E-4A68-B59D-E82E1C8A76FEQ38263353-AD3E3819-CB0A-40DA-9CFB-B7A7C01BAA13Q38367715-C3A72958-91D2-41E7-B51F-A8D23F2C83CBQ38609596-D714279B-03AD-402D-B6CB-BB61B021155AQ38736947-B49C806A-3F4B-4616-AED3-BE2BBB46B58CQ38900557-7E336C26-C4E3-4744-A659-3B9857FD5EE7Q39445552-F37386A1-EC17-4F65-882C-2EC69D63BA6EQ45018784-04154F8D-F56D-4C6D-9022-FD291B6BA572Q49207905-E4C629EB-8F40-46A5-A2F0-382786478CA2Q51609969-0FACC605-4225-4E75-B485-E42414D0A792Q53264477-0AB64FAA-38BF-4131-8911-EAE307D5B19DQ57947066-76E66308-7A0E-4AC7-BB96-D6A8A365B3FD
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Molecular mechanisms and treatment of bone metastasis.
@ast
Molecular mechanisms and treatment of bone metastasis.
@en
type
label
Molecular mechanisms and treatment of bone metastasis.
@ast
Molecular mechanisms and treatment of bone metastasis.
@en
prefLabel
Molecular mechanisms and treatment of bone metastasis.
@ast
Molecular mechanisms and treatment of bone metastasis.
@en
P2860
P1476
Molecular mechanisms and treatment of bone metastasis.
@en
P2093
Gregory A Clines
P2860
P356
10.1017/S1462399408000616
P577
2008-03-06T00:00:00Z